Kevin Takakuwa, MD, forwards a bill before the California legislature that solidifies control of marijuana research by UC San Diego. Here is the Legislative Counsel’s Digest, with a troubling line boldfaced:
AB 1996, as amended, Lackey. The California Cannabis Research Program.
Existing law, if the Regents of the University of California accept the responsibility, requires the University of California to establish the California Cannabis Research Program, also sometimes referred to as the California Marijuana Research Program or the Center for Medicinal Cannabis Research, in order to develop and conduct studies intended to ascertain the general medical safety and efficacy of cannabis, among other duties. Existing law, the Control, Regulate and Tax Adult Use of Marijuana Act (AUMA), an initiative statute approved by the voters at the November 8, 2016, statewide general election as Proposition 64, among other things, establishes the California Cannabis Tax Fund as a continuously appropriated fund consisting of specified taxes, interest, penalties, and other amounts imposed by AUMA. AUMA requires, after other specified disbursements are made from the fund, the Controller to disburse $2,000,000 to the University of San Diego Center for Medicinal Cannabis Research.This bill would conform the name of the program throughout the code, including for purposes of the appropriation made by AUMA, as the California Cannabis Research Program and would specify that the program is hosted by the Center for Cannabis Research. The bill would authorize the program to cultivate cannabis for its use in research, as specified. The bill would expand the purview of the program to include the study of naturally occurring constituents of cannabis and synthetic compounds that have effects similar to naturally occurring cannabinoids and would also authorize the controlled clinical trials to focus on examining testing methods for detecting harmful contaminants in cannabis, including mold and bacteria. The bill would prohibit the use of specified funds from the California Cannabis Tax Fund from being used for these purposes.
Neoprobe cannabis “experts”in Academia are casting covetous eyes on state tax money. Check out the concluding paragraph of this April 2 essay in JAMA by Dr. Kevin Hill… Hill was Harvard Med School’s “counterpoint” speaker when Lester Grinspoon was invited to give a talk in 2013, as recounted here.